RIO DE JANEIRO, BRAZIL - The employees of the Cuban Biotechnology and Pharmaceutical Industry Group (Biocubafarma) are currently working intensively in the fight against the coronavirus pandemic and are developing research in various directions.
They are focusing on the development of drugs to boost the immune systems of high-risk individuals, on drugs with antiviral effects, and on drugs to prevent the death of seriously or critically ill patients.
The Biocubafarma is currently working on 15 projects to prevent and fight Covid-19, the disease caused by the novel coronavirus SARS-Cov-2.
Dr. Eduardo Martinez, President of the state-owned . . .